Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention1: study group 1 in this GFC for the management of androgenic alopecia: 10 ml of venous autologous whole blood will be collected into GFC tubes. The blood will be gently mixed by invertin
Sponsors
Dr Palak Chouhan
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients between age of 20-65 years of both genders. 2. Type I and Type II Patients indicated for the management of androgenic Alopecia as per Bouhanna s classification for male and Ludwig s classification for female 3. Healthy patients falling under ASA I and ASA II 4. Subjects able and willing to provide written informed consent and compliant with study procedure.
Exclusion criteria
Exclusion criteria: 1. Patients who had not received any topical or systemic treatment for their hair loss during the last 3 months 2. Patient with history of having anticoagulant therapy 3. Patients having history of autoimmune disorder, haematological disorder and platelet dysfunction syndrome. 4. Patients with a history of immunosuppression (malignancy, chemotherapy, steroid therapy), dermatological acute infections and diseases other than androgenic alopecia affecting the scalp. 5. Patient is under regular analgesics and anti-depressants. 6. Having previous history of radiation therapy in the head and neck region. 7. Pregnant and nursing women. 8. Patients with a history of hair transplant. 9. Patient having tendency for the keloid formation. 10. Patient who has already received PRP and GFC treatment for more than 3 sittings within 3 months 11. Patients with the history of immunodeficiency virus (HIV, hepatitis B and hepatitis C)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Preoperative: 1. Hair-pull test 2. Hair density with the help of trichoscope 3. Patient satisfaction Immediate postoperative: 1. Pain on visual analogue scale while injecting PRP or GFC Postoperative: 1. Hair-pull test 2. Hair density with the help of trichoscope 3. Patient satisfaction 4. Investigator satisfaction Timepoint: Day O and Postoperatively On 1st, 2nd, 3rd and 4th month postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| any other complicationTimepoint: On 1st, 2nd, 3rd and 4th month postoperatively | — |
Countries
India
Contacts
Public ContactShallu Bansal
Geetanjali Dental and Research Institute
Outcome results
None listed